NHS England has published the final 23 Patient Group Directions (PGDs) and protocol for the Pharmacy First service, which is due to start on 31st January 2024. Draft versions of the PGDs and protocols were published on the NHS Business Services Authority’s website on 1st December 2023, to help pharmacists and pharmacy owners to start [...]
The post Pharmacy First: Final PGDs and protocol published appeared first on Community Pharmacy England.
Department of Health and Social Care (DHSC) has issued a medicine supply notification for Glucagon (GlucaGen®) 1mg powder for injection kit . MSN/2023/051 Tier 2 – medium impact Date of issue 18th December 2023 There are two licensed glucagon preparations: GlucaGen® (1mg powder for injection kit) and Ogluo® (0.5mg and 1mg pre-filled auto-injector pens) There [...]
The post Medicine Supply Notification: Glucagon (GlucaGen®) 1mg powder for injection kit appeared first on Community Pharmacy England.
Department of Health and Social Care (DHSC) has issued a medicine supply notification for Oxybutynin 5mg modified-release tablets. MSN/2023/116 Tier 2 – medium impact Date of issue 18th December 2023 Oxybutynin 5mg modified-release tablets are out of stock until early April 2024. Oxybutynin immediate release formulations (tablets and liquid) remain available and can support increased [...]
The post Medicine Supply Notification: Oxybutynin 5mg modified-release tablets appeared first on Community Pharmacy England.
It is just over six weeks till the Pharmacy First service is due to start (31st January 2024); community pharmacists in England are reminded that they can access NHS England funded Community Pharmacy Clinical Examination Skills training, which may be particularly helpful for supporting delivery of this service. The training, which is being delivered by [...]
The post Free clinical examination training plus otoscope training webinar appeared first on Community Pharmacy England.
A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 17 Issue 5 December 2023) has been published and includes articles on: Aripiprazole (Abilify and generic brands): risk of pathological gambling Vitamin B12 (hydroxocobalamin, cyanocobalamin): advise patients with known cobalt allergy to be vigilant for sensitivity reactions Letters and medicine recalls sent [...]
The post MHRA Drug Safety Update: December 2023 appeared first on Community Pharmacy England.
Recent Comments